Elanco Animal Health (ELAN) Shares Outstanding (2017 - 2026)

Elanco Animal Health has disclosed Shares Outstanding (Entity) across 10 years of filings, most recently posting $499.5 million for Q2 2026.

• In Q2 2026, Shares Outstanding (Entity) rose 0.58% year-over-year to $499.5 million; the TTM figure through Jun 2026 stood at $499.5 million (up 0.58% YoY), while the FY2025 annual figure was $497.0 million, up 0.51% from the prior year.
• Shares Outstanding (Entity) came in at $499.5 million for Q2 2026 at Elanco Animal Health, roughly flat from $499.4 million in the prior quarter.
• In the past five years, Shares Outstanding (Entity) ranged from a high of $499.5 million in Q2 2026 to a low of $474.1 million in Q1 2022.
• Average Shares Outstanding (Entity) over 5 years is $490.6 million, with a median of $494.1 million recorded in 2024.
• Year-over-year, Shares Outstanding (Entity) rose 0.23% in 2022 and grew 3.92% in 2023.
• Over 5 years, Shares Outstanding (Entity) stood at $474.2 million in 2022, then rose by 3.92% to $492.8 million in 2023, then rose by 0.32% to $494.4 million in 2024, then advanced by 0.51% to $497.0 million in 2025, then increased by 0.52% to $499.5 million in 2026.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $499.5 million in Q2 2026, $499.4 million in Q1 2026, and $497.0 million in Q4 2025.